The Drug and Gene Delivery Devices Market is Primed for Growth Driven by Advanced Therapies

The Drug and Gene Delivery Devices Market is Primed for Growth Driven by Advanced Therapies

The drug and gene delivery devices market involves medical devices that safely administer therapeutic drugs, biologics or genes into the body. Devices such as needle-free injectors, transdermal drug delivery systems and inhalers aim to improve patient convenience and compliance while reducing injection pain and risks. With growing cases of cancer, diabetes and cardiac disorders worldwide, demand for pain-free and effective drug delivery solutions continues to rise at a robust pace.

The global drug and gene delivery devices market is estimated to be valued at US$ 25.9 Bn in 2024 and is expected to exhibit a CAGR of 6.9% over the forecast period 2024 To 2031.

Key Takeaways

Key players operating in the drug and gene delivery devices market are Change Healthcare (Now part of Optum, UnitedHealth Group), Cognizant, McKesson Corporation, Cerner Corporation, OptumInsight (UnitedHealth Group), TriZetto (A Cognizant Company), NTT DATA Corporation, MultiPlan, Athenahealth (Now part of Veritas Capital), Allscripts Healthcare Solutions, Experian Health, eClinicalWorks, Inovalon, Mphasis, Wipro.

Growing investments by pharmaceutical companies in advanced therapies, including gene therapy, cell therapy, and tissue-engineered products, are driving the expansion of the drug and gene delivery devices market size on a global scale. Major players are actively collaborating with biotech startups and academic institutes engaged in novel drug development to penetrate emerging markets.

Globally, the drug and gene delivery devices market is expected to witness high growth in the Asia Pacific region owing to rising healthcare investments, increasing generic drug production and growing medical tourism in countries such as India and China.

Market Drivers

The growing prevalence of chronic diseases such as cancer, cardiac disorders and diabetes across the world is a key market driver. These patients require long term pharmacological treatments which fuel demand for pain-free, controlled and targeted drug delivery devices. Additionally, increasing investments by governments and private players in advanced drug delivery technologies is also supporting the market growth.

PEST Analysis
Political: Regulations regarding drug and gene delivery devices with respect to approvals and manufacturing have a significant influence on the market. Stringent regulatory processes impact product launches and costs.

Economic: Changes in global healthcare spending and reimbursement policies impact the adoption of new devices. Cost pressures and budget constraints posed challenges for market players.

Social: The drug and gene delivery devices market challenges and opportunities significant R&D investments and clinical validations before they can establish themselves as viable alternatives to existing devices. However, these challenges also present opportunities for innovation and the development of advanced delivery technologies that can meet unmet medical needs.

Technological: Innovation in materials, miniaturization, and digital technologies facilitate the development of more targeted and personalized delivery systems. Advances in 3D printing, biologics, and wearables open new avenues.

Geographical Regions

North America accounts for the largest share of the global market currently due to advanced healthcare infrastructure and availability of reimbursements. The United States contributes heavily owing to a large patient population and considerable investments in R&D by players. Growing medical tourism and healthcare reforms are boosting the Asia Pacific market with China and India emerging as lucrative markets.

Fastest Growing Regional Market
The Asia Pacific region is expected to witness the fastest growth over the forecast period supported by rising medical expenditures, increasing prevalence of chronic diseases, growing geriatric population, and improving access to healthcare in developing countries. China, Japan and India are major contributors to the expanding APAC drug and gene delivery devices market with frequent new product launches and strategic investments by global industry players looking to tap the high-potential regional markets.

Identify the language that you favor

French German Italian Russian Japanese Chinese Korean Portuguese

About Author:

Vaagisha brings over three years of expertise as a content editor in the market research domain. Originally a creative writer, she discovered her passion for editing, combining her flair for writing with a meticulous eye for detail. Her ability to craft and refine compelling content makes her an invaluable asset in delivering polished and engaging write-ups.

(LinkedIn: https://www.linkedin.com/in/vaagisha-singh-8080b91)